Board Appointment

Report this content

9 November 2021

International Personal Finance plc ("IPF")

Board Appointment

International Personal Finance plc, is pleased to announce the appointment of Gary Thompson to the Board as Chief Financial Officer ("CFO").  His appointment will take effect from 4 April 2022.

Gary has been the Finance Director of Vanquis Bank Limited, the major subsidiary of Provident Financial plc, since May 2020.  He has nearly 20 years' financial services experience spent in both the accounting and corporate sectors. He qualified as a Chartered Accountant in 1997 at PricewaterhouseCoopers and spent 10 years working in professional practice. He joined Provident Financial plc in August 2004 where he performed a number of finance roles, more latterly as Director of Group Finance and Investor Relations, prior to his appointment at Vanquis Bank.

Gerard Ryan, Chief Executive Officer of IPF, commented: "We are delighted that Gary is joining our business. He brings a wealth of sector-specific experience and skills, and will be a strong addition to the IPF leadership team. After a thorough and extensive search process, the Board unanimously concluded that Gary's experience and record of high performance made him an excellent fit for our CFO role."

Gary Thompson commented: "I am thrilled to be joining International Personal Finance as its new Chief Financial Officer. I look forward to working with Gerard, the Board and the wider team as we continue to play an essential role in society by providing credit to the underserved, executing on our strategy and delivering sustainable returns to shareholders."

There are no disclosures required pursuant to Listing Rule 9.6.13.

For further information please contact:

Rachel Moran - Investor Relations: +44(0)7760 167637 / +44 (0)113 539 5466

Legal Entity Identifier Number: 213800II1O44IRKUZB59

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit


Documents & Links